GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Lhx2
|
ENSRNOG00000010551 | LIM homeobox 2 |
Hoxc5
|
ENSRNOG00000016598 | homeo box C5 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hoxc5 | rn6_v1_chr7_+_144628120_144628120 | 0.40 | 1.3e-13 | Click! |
Lhx2 | rn6_v1_chr3_+_22640545_22640604 | -0.40 | 1.6e-13 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_+_101791337 | 27.70 |
ENSRNOT00000046937
|
Slc5a12
|
solute carrier family 5 member 12 |
chr10_-_34242985 | 22.80 |
ENSRNOT00000046438
|
RGD1559575
|
similar to novel protein |
chr2_+_200793571 | 19.96 |
ENSRNOT00000091444
|
Hao2
|
hydroxyacid oxidase 2 |
chr3_+_171213936 | 19.59 |
ENSRNOT00000031586
|
Pck1
|
phosphoenolpyruvate carboxykinase 1 |
chr18_-_15089988 | 19.31 |
ENSRNOT00000074116
|
Mep1b
|
meprin A subunit beta |
chr13_-_83457888 | 19.17 |
ENSRNOT00000076289
ENSRNOT00000004065 |
Sft2d2
|
SFT2 domain containing 2 |
chr3_+_159368273 | 18.87 |
ENSRNOT00000041688
|
Sgk2
|
serum/glucocorticoid regulated kinase 2 |
chr1_-_189182306 | 18.77 |
ENSRNOT00000021249
|
Gp2
|
glycoprotein 2 |
chrM_+_9870 | 18.40 |
ENSRNOT00000044582
|
Mt-nd4l
|
mitochondrially encoded NADH 4L dehydrogenase |
chr1_-_189181901 | 16.71 |
ENSRNOT00000092022
|
Gp2
|
glycoprotein 2 |
chr6_-_7058314 | 16.63 |
ENSRNOT00000045996
|
Haao
|
3-hydroxyanthranilate 3,4-dioxygenase |
chr5_+_6373583 | 16.62 |
ENSRNOT00000084749
|
AABR07046778.1
|
|
chr6_+_8284878 | 16.55 |
ENSRNOT00000009581
|
Slc3a1
|
solute carrier family 3 member 1 |
chr4_+_88694583 | 16.40 |
ENSRNOT00000009202
|
Ppm1k
|
protein phosphatase, Mg2+/Mn2+ dependent, 1K |
chr8_+_85059051 | 15.78 |
ENSRNOT00000033196
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit |
chr2_+_60337667 | 15.78 |
ENSRNOT00000024035
|
Agxt2
|
alanine-glyoxylate aminotransferase 2 |
chr13_-_50514151 | 15.63 |
ENSRNOT00000003951
|
Ren
|
renin |
chrM_+_10160 | 15.33 |
ENSRNOT00000042928
|
Mt-nd4
|
mitochondrially encoded NADH dehydrogenase 4 |
chr17_-_9762813 | 14.83 |
ENSRNOT00000033749
|
Slc34a1
|
solute carrier family 34 member 1 |
chr4_+_61814974 | 14.77 |
ENSRNOT00000074951
|
Akr1b10
|
aldo-keto reductase family 1 member B10 |
chr9_-_4876023 | 14.31 |
ENSRNOT00000065839
|
RGD1559960
|
similar to Sulfotransferase K1 (rSULT1C2) |
chr3_-_94808861 | 13.80 |
ENSRNOT00000038464
|
Prrg4
|
proline rich and Gla domain 4 |
chr13_-_67206688 | 13.28 |
ENSRNOT00000003630
ENSRNOT00000090693 |
Pla2g4a
|
phospholipase A2 group IVA |
chr8_-_84320714 | 13.03 |
ENSRNOT00000079356
ENSRNOT00000088487 |
Tinag
|
tubulointerstitial nephritis antigen |
chr13_-_77821312 | 13.02 |
ENSRNOT00000082110
|
AABR07021544.1
|
|
chr3_-_76518601 | 12.76 |
ENSRNOT00000071021
|
Olr623
|
olfactory receptor 623 |
chr19_-_37796089 | 12.46 |
ENSRNOT00000024891
|
Ranbp10
|
RAN binding protein 10 |
chr1_-_267463694 | 12.28 |
ENSRNOT00000084851
ENSRNOT00000016645 |
Col17a1
|
collagen type XVII alpha 1 chain |
chr9_+_4107246 | 12.18 |
ENSRNOT00000078212
|
AABR07066160.1
|
|
chr17_+_69761118 | 11.85 |
ENSRNOT00000023739
|
Akr1c3
|
aldo-keto reductase family 1, member C3 |
chr2_+_256964860 | 11.76 |
ENSRNOT00000073547
|
Ifi44l
|
interferon-induced protein 44-like |
chr1_-_224698514 | 11.72 |
ENSRNOT00000024234
|
Slc22a25
|
solute carrier family 22, member 25 |
chr2_-_216382244 | 11.62 |
ENSRNOT00000086695
ENSRNOT00000087259 |
LOC103689940
|
pancreatic alpha-amylase-like |
chr19_+_15081590 | 11.44 |
ENSRNOT00000024187
|
Ces1f
|
carboxylesterase 1F |
chr3_+_159936856 | 11.31 |
ENSRNOT00000078703
|
Hnf4a
|
hepatocyte nuclear factor 4, alpha |
chr1_-_73399579 | 11.31 |
ENSRNOT00000077186
|
Lilrb4
|
leukocyte immunoglobulin like receptor B4 |
chr2_-_216348194 | 11.24 |
ENSRNOT00000087839
|
LOC103689940
|
pancreatic alpha-amylase-like |
chr11_+_85263536 | 11.21 |
ENSRNOT00000046465
|
AABR07034729.1
|
|
chr4_-_176381477 | 10.82 |
ENSRNOT00000048367
|
Slco1a6
|
solute carrier organic anion transporter family, member 1a6 |
chrM_+_7919 | 10.81 |
ENSRNOT00000046108
|
Mt-atp6
|
mitochondrially encoded ATP synthase 6 |
chr1_+_32221636 | 10.78 |
ENSRNOT00000022346
ENSRNOT00000089941 |
Slc6a18
|
solute carrier family 6 member 18 |
chr18_+_55466373 | 10.71 |
ENSRNOT00000074629
|
LOC102555392
|
interferon-inducible GTPase 1-like |
chrM_+_7006 | 10.50 |
ENSRNOT00000043693
|
Mt-co2
|
mitochondrially encoded cytochrome c oxidase II |
chr5_-_12172009 | 10.05 |
ENSRNOT00000061903
|
Pcmtd1
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 |
chr8_+_49713190 | 10.05 |
ENSRNOT00000022074
|
Fxyd2
|
FXYD domain-containing ion transport regulator 2 |
chr9_+_95161157 | 10.01 |
ENSRNOT00000071200
|
Ugt1a5
|
UDP glucuronosyltransferase family 1 member A5 |
chr5_+_24410863 | 9.98 |
ENSRNOT00000010591
|
Tp53inp1
|
tumor protein p53 inducible nuclear protein 1 |
chr1_+_150310319 | 9.89 |
ENSRNOT00000042081
|
Olr34
|
olfactory receptor 34 |
chr20_+_32717564 | 9.88 |
ENSRNOT00000030642
|
Rfx6
|
regulatory factor X, 6 |
chr9_+_8054466 | 9.88 |
ENSRNOT00000081513
|
Adgre4
|
adhesion G protein-coupled receptor E4 |
chr4_+_31229913 | 9.82 |
ENSRNOT00000077134
ENSRNOT00000087897 |
Samd9l
|
sterile alpha motif domain containing 9-like |
chr4_+_148782479 | 9.81 |
ENSRNOT00000018133
|
LOC500300
|
similar to hypothetical protein MGC6835 |
chr14_-_6533524 | 9.78 |
ENSRNOT00000079795
|
Abcg3l1
|
ATP-binding cassette, subfamily G (WHITE), member 3-like 1 |
chrM_+_11736 | 9.77 |
ENSRNOT00000048767
|
Mt-nd5
|
mitochondrially encoded NADH dehydrogenase 5 |
chr13_+_89386023 | 9.74 |
ENSRNOT00000086223
|
Fcgr3a
|
Fc fragment of IgG receptor IIIa |
chr1_+_48273611 | 9.72 |
ENSRNOT00000022254
ENSRNOT00000022068 |
Slc22a1
|
solute carrier family 22 member 1 |
chr20_+_3176107 | 9.70 |
ENSRNOT00000001036
|
RT1-S3
|
RT1 class Ib, locus S3 |
chr4_-_117607428 | 9.47 |
ENSRNOT00000021243
|
LOC103690139
|
probable N-acetyltransferase CML6 |
chr10_-_82117109 | 9.40 |
ENSRNOT00000079711
|
Abcc3
|
ATP binding cassette subfamily C member 3 |
chr7_-_107768072 | 9.39 |
ENSRNOT00000093189
|
Ndrg1
|
N-myc downstream regulated 1 |
chr3_-_14643897 | 9.37 |
ENSRNOT00000082008
ENSRNOT00000025983 |
Ggta1
|
glycoprotein, alpha-galactosyltransferase 1 |
chr4_+_88184956 | 9.37 |
ENSRNOT00000077129
|
Vom1r83
|
vomeronasal 1 receptor 83 |
chr3_+_20303979 | 9.31 |
ENSRNOT00000058331
|
AABR07051730.1
|
|
chr9_+_61692154 | 9.29 |
ENSRNOT00000082300
|
Hspe1
|
heat shock protein family E member 1 |
chr6_-_140880070 | 9.28 |
ENSRNOT00000073779
|
LOC691828
|
uncharacterized LOC691828 |
chr14_-_64476796 | 9.26 |
ENSRNOT00000029104
|
Gba3
|
glucosidase, beta, acid 3 |
chrM_+_3904 | 9.20 |
ENSRNOT00000040993
|
Mt-nd2
|
mitochondrially encoded NADH dehydrogenase 2 |
chr7_+_71057911 | 9.16 |
ENSRNOT00000037218
|
Rdh16
|
retinol dehydrogenase 16 (all-trans) |
chr3_-_154627257 | 8.91 |
ENSRNOT00000018328
|
Tgm2
|
transglutaminase 2 |
chr2_+_23289374 | 8.68 |
ENSRNOT00000090666
ENSRNOT00000032783 |
Dmgdh
|
dimethylglycine dehydrogenase |
chr4_-_71229575 | 8.59 |
ENSRNOT00000076650
|
Tcaf2
|
TRPM8 channel-associated factor 2 |
chr10_+_69412017 | 8.54 |
ENSRNOT00000009448
|
Ccl2
|
C-C motif chemokine ligand 2 |
chr4_-_163463718 | 8.49 |
ENSRNOT00000085671
|
Klrc1
|
killer cell lectin like receptor C1 |
chr4_-_70628470 | 8.48 |
ENSRNOT00000029319
|
Try5
|
trypsin 5 |
chr20_-_9855443 | 8.40 |
ENSRNOT00000090275
ENSRNOT00000066266 |
Tff3
|
trefoil factor 3 |
chr4_+_88328061 | 8.37 |
ENSRNOT00000084775
|
Vom1r87
|
vomeronasal 1 receptor 87 |
chrX_+_37329779 | 8.34 |
ENSRNOT00000038352
ENSRNOT00000088802 |
Pdha1
|
pyruvate dehydrogenase (lipoamide) alpha 1 |
chr2_-_200513564 | 8.21 |
ENSRNOT00000056173
|
Phgdh
|
phosphoglycerate dehydrogenase |
chr1_-_101095594 | 8.17 |
ENSRNOT00000027944
|
Fcgrt
|
Fc fragment of IgG receptor and transporter |
chr13_+_82369493 | 8.11 |
ENSRNOT00000003733
|
Sell
|
selectin L |
chr2_+_60169517 | 8.06 |
ENSRNOT00000080974
|
Prlr
|
prolactin receptor |
chr10_-_90307658 | 8.05 |
ENSRNOT00000092102
|
Slc4a1
|
solute carrier family 4 member 1 |
chrM_+_7758 | 7.92 |
ENSRNOT00000046201
|
Mt-atp8
|
mitochondrially encoded ATP synthase 8 |
chr4_+_157107469 | 7.81 |
ENSRNOT00000015678
|
C1rl
|
complement C1r subcomponent like |
chr10_+_95770154 | 7.80 |
ENSRNOT00000030300
|
Helz
|
helicase with zinc finger |
chr3_-_14229067 | 7.80 |
ENSRNOT00000025534
ENSRNOT00000092865 |
C5
|
complement C5 |
chr4_-_72074683 | 7.64 |
ENSRNOT00000071511
|
Fam115c
|
family with sequence similarity 115, member C |
chr2_+_80269661 | 7.58 |
ENSRNOT00000015975
|
AABR07008940.1
|
|
chr1_-_263803150 | 7.58 |
ENSRNOT00000017840
|
Cyp2c23
|
cytochrome P450, family 2, subfamily c, polypeptide 23 |
chr14_-_45859908 | 7.57 |
ENSRNOT00000086994
|
Pgm2
|
phosphoglucomutase 2 |
chr9_-_105693357 | 7.56 |
ENSRNOT00000066968
|
Nudt12
|
nudix hydrolase 12 |
chr20_+_3246739 | 7.50 |
ENSRNOT00000061299
|
RT1-T24-2
|
RT1 class I, locus T24, gene 2 |
chr12_-_46493203 | 7.47 |
ENSRNOT00000057036
|
Cit
|
citron rho-interacting serine/threonine kinase |
chr3_+_19690016 | 7.43 |
ENSRNOT00000085460
|
AABR07051707.1
|
|
chr20_-_45053640 | 7.43 |
ENSRNOT00000072256
|
RGD1561777
|
similar to Na+ dependent glucose transporter 1 |
chrM_+_8599 | 7.40 |
ENSRNOT00000049683
|
Mt-cox3
|
mitochondrially encoded cytochrome C oxidase III |
chr19_+_15081158 | 7.37 |
ENSRNOT00000074070
|
Ces1f
|
carboxylesterase 1F |
chr8_+_85489553 | 7.33 |
ENSRNOT00000082158
|
Rpl12-ps1
|
ribosomal protein L12, pseudogene 1 |
chr15_+_42808897 | 7.30 |
ENSRNOT00000023475
|
Chrna2
|
cholinergic receptor nicotinic alpha 2 subunit |
chrX_-_15347591 | 7.29 |
ENSRNOT00000037066
|
Timm17b
|
translocase of inner mitochondrial membrane 17b |
chr2_+_248398917 | 7.29 |
ENSRNOT00000045855
|
Gbp1
|
guanylate binding protein 1 |
chr1_+_140998240 | 7.20 |
ENSRNOT00000023506
ENSRNOT00000090897 |
Abhd2
|
abhydrolase domain containing 2 |
chr3_+_16753703 | 7.11 |
ENSRNOT00000077741
|
AABR07051548.2
|
|
chr8_+_2604962 | 7.01 |
ENSRNOT00000009993
|
Casp1
|
caspase 1 |
chr20_-_14020007 | 6.91 |
ENSRNOT00000093521
|
Ggt1
|
gamma-glutamyltransferase 1 |
chr3_+_72134731 | 6.88 |
ENSRNOT00000083592
|
Ypel4
|
yippee-like 4 |
chr2_+_187447501 | 6.78 |
ENSRNOT00000038589
|
Iqgap3
|
IQ motif containing GTPase activating protein 3 |
chr1_+_229519506 | 6.76 |
ENSRNOT00000016593
|
Glyatl2
|
glycine-N-acyltransferase-like 2 |
chr1_-_116153722 | 6.72 |
ENSRNOT00000041605
|
Fpr3
|
formyl peptide receptor 3 |
chr6_-_143195445 | 6.61 |
ENSRNOT00000078672
|
AABR07065837.1
|
|
chr4_-_163762434 | 6.45 |
ENSRNOT00000081854
|
Ly49si1
|
immunoreceptor Ly49si1 |
chr2_+_220432037 | 6.45 |
ENSRNOT00000021988
|
Frrs1
|
ferric-chelate reductase 1 |
chr7_-_15073052 | 6.43 |
ENSRNOT00000037708
|
Zfp799
|
zinc finger protein 799 |
chr4_-_165026414 | 6.41 |
ENSRNOT00000071421
|
Klra1
|
killer cell lectin-like receptor, subfamily A, member 1 |
chr4_-_64981384 | 6.38 |
ENSRNOT00000017338
|
Creb3l2
|
cAMP responsive element binding protein 3-like 2 |
chr3_+_17889972 | 6.36 |
ENSRNOT00000073021
|
AABR07051611.1
|
|
chr14_+_5928737 | 6.32 |
ENSRNOT00000071877
ENSRNOT00000040985 ENSRNOT00000074889 |
Mpa2l
|
macrophage activation 2 like |
chr10_-_57837602 | 6.31 |
ENSRNOT00000075185
|
Nlrp1b
|
NLR family, pyrin domain containing 1B |
chr9_+_71915421 | 6.29 |
ENSRNOT00000020447
|
Pikfyve
|
phosphoinositide kinase, FYVE-type zinc finger containing |
chr9_+_95202632 | 6.27 |
ENSRNOT00000025652
|
Ugt1a5
|
UDP glucuronosyltransferase family 1 member A5 |
chr6_-_122239614 | 6.24 |
ENSRNOT00000005015
|
Galc
|
galactosylceramidase |
chr7_+_18068060 | 6.23 |
ENSRNOT00000065474
|
Vom1r107
|
vomeronasal 1 receptor 107 |
chr7_-_3707226 | 6.23 |
ENSRNOT00000064380
|
Olr879
|
olfactory receptor 879 |
chr6_-_111417813 | 6.21 |
ENSRNOT00000016324
ENSRNOT00000085458 |
Sptlc2
|
serine palmitoyltransferase, long chain base subunit 2 |
chr2_+_251983339 | 6.06 |
ENSRNOT00000020230
|
Mcoln3
|
mucolipin 3 |
chr18_-_41389510 | 6.02 |
ENSRNOT00000005476
ENSRNOT00000005446 |
Sema6a
|
semaphorin 6A |
chr1_+_141767940 | 6.01 |
ENSRNOT00000064034
|
Zfp710
|
zinc finger protein 710 |
chr2_+_186776644 | 6.00 |
ENSRNOT00000046778
|
Fcrl3
|
Fc receptor-like 3 |
chr2_-_33025271 | 5.99 |
ENSRNOT00000074941
|
NEWGENE_1310139
|
microtubule associated serine/threonine kinase family member 4 |
chr4_-_88684415 | 5.98 |
ENSRNOT00000009001
|
LOC500148
|
similar to 40S ribosomal protein S7 (S8) |
chr1_-_38538987 | 5.96 |
ENSRNOT00000090406
ENSRNOT00000071275 |
LOC102551340
|
zinc finger protein 728-like |
chr13_-_78885464 | 5.95 |
ENSRNOT00000003828
|
Dars2
|
aspartyl-tRNA synthetase 2 (mitochondrial) |
chr14_-_38128015 | 5.95 |
ENSRNOT00000090303
ENSRNOT00000034642 |
Nipal1
|
NIPA-like domain containing 1 |
chr5_-_147412705 | 5.94 |
ENSRNOT00000010688
|
RGD1561149
|
similar to mKIAA1522 protein |
chr7_+_29435444 | 5.92 |
ENSRNOT00000008613
|
Slc5a8
|
solute carrier family 5 member 8 |
chr5_+_58995249 | 5.91 |
ENSRNOT00000023411
|
Ccdc107
|
coiled-coil domain containing 107 |
chr8_+_128027958 | 5.90 |
ENSRNOT00000045049
|
Acaa1b
|
acetyl-Coenzyme A acyltransferase 1B |
chr1_+_213686046 | 5.89 |
ENSRNOT00000019808
|
LOC108348167
|
NACHT, LRR and PYD domains-containing protein 6-like |
chr2_-_192288568 | 5.81 |
ENSRNOT00000067346
|
AABR07012291.2
|
|
chr20_+_13817795 | 5.81 |
ENSRNOT00000036518
|
Gstt3
|
glutathione S-transferase, theta 3 |
chr4_-_164453171 | 5.79 |
ENSRNOT00000077539
ENSRNOT00000083610 ENSRNOT00000079975 |
Ly49s6
|
Ly49 stimulatory receptor 6 |
chr7_-_71139267 | 5.79 |
ENSRNOT00000065232
|
RGD1561812
|
similar to Retinol dehydrogenase type II (RODH II) (29 k-protein) |
chr1_-_166939541 | 5.74 |
ENSRNOT00000079675
|
Folr1
|
folate receptor 1 |
chr16_-_29936307 | 5.73 |
ENSRNOT00000088707
|
Ddx60
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 |
chr1_-_263762785 | 5.71 |
ENSRNOT00000018221
|
Cpn1
|
carboxypeptidase N subunit 1 |
chr1_+_213676954 | 5.70 |
ENSRNOT00000050551
|
Nlrp6
|
NLR family, pyrin domain containing 6 |
chr4_+_163174487 | 5.69 |
ENSRNOT00000088108
|
Clec9a
|
C-type lectin domain family 9, member A |
chr2_-_147392062 | 5.68 |
ENSRNOT00000021535
|
Tm4sf1
|
transmembrane 4 L six family member 1 |
chr1_-_224533219 | 5.62 |
ENSRNOT00000051289
|
Ust5r
|
integral membrane transport protein UST5r |
chr14_-_84662143 | 5.61 |
ENSRNOT00000057529
ENSRNOT00000080078 |
Hormad2
|
HORMA domain containing 2 |
chr6_+_139405966 | 5.60 |
ENSRNOT00000088974
|
AABR07065693.3
|
|
chr12_-_24775891 | 5.58 |
ENSRNOT00000074851
|
Wbscr27
|
Williams Beuren syndrome chromosome region 27 |
chr3_+_119561290 | 5.56 |
ENSRNOT00000015843
|
Blvra
|
biliverdin reductase A |
chr2_+_30685840 | 5.56 |
ENSRNOT00000031385
|
Ccdc125
|
coiled-coil domain containing 125 |
chr4_+_1591444 | 5.53 |
ENSRNOT00000078277
|
Olr1245
|
olfactory receptor 1245 |
chr15_-_93765498 | 5.51 |
ENSRNOT00000093297
|
Mycbp2
|
MYC binding protein 2, E3 ubiquitin protein ligase |
chr17_-_43504604 | 5.48 |
ENSRNOT00000083829
ENSRNOT00000066313 |
Slc17a1
|
solute carrier family 17 member 1 |
chr7_-_142318620 | 5.46 |
ENSRNOT00000006351
|
Cela1
|
chymotrypsin-like elastase family, member 1 |
chr1_+_61786900 | 5.42 |
ENSRNOT00000090287
|
AABR07001905.1
|
|
chrM_+_9451 | 5.39 |
ENSRNOT00000041241
|
Mt-nd3
|
mitochondrially encoded NADH dehydrogenase 3 |
chr17_-_43807540 | 5.36 |
ENSRNOT00000074763
|
LOC684762
|
similar to CG31613-PA |
chrM_-_14061 | 5.35 |
ENSRNOT00000051268
|
Mt-nd6
|
mitochondrially encoded NADH dehydrogenase 6 |
chr4_+_166993669 | 5.30 |
ENSRNOT00000045376
|
Tas2r109
|
taste receptor, type 2, member 109 |
chr10_+_84966989 | 5.27 |
ENSRNOT00000013580
|
Scrn2
|
secernin 2 |
chr20_+_44680449 | 5.26 |
ENSRNOT00000000728
|
Traf3ip2
|
Traf3 interacting protein 2 |
chr16_-_37177033 | 5.26 |
ENSRNOT00000014015
|
Fbxo8
|
F-box protein 8 |
chr4_+_88207124 | 5.25 |
ENSRNOT00000082459
|
Vom1r84
|
vomeronasal 1 receptor 84 |
chr4_+_99823252 | 5.25 |
ENSRNOT00000013587
|
Polr1a
|
RNA polymerase I subunit A |
chr17_-_79085076 | 5.24 |
ENSRNOT00000057851
|
Fam171a1
|
family with sequence similarity 171, member A1 |
chr10_-_34961349 | 5.24 |
ENSRNOT00000004885
|
LOC103689931
|
heterogeneous nuclear ribonucleoprotein A/B |
chr1_-_256734719 | 5.23 |
ENSRNOT00000021546
ENSRNOT00000089456 |
Myof
|
myoferlin |
chr11_+_54619129 | 5.21 |
ENSRNOT00000059924
|
Trat1
|
T cell receptor associated transmembrane adaptor 1 |
chr13_-_80775230 | 5.17 |
ENSRNOT00000091389
ENSRNOT00000004762 |
Fmo2
|
flavin containing monooxygenase 2 |
chr19_-_601469 | 5.17 |
ENSRNOT00000016462
|
Pdp2
|
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
chr3_+_20163337 | 5.16 |
ENSRNOT00000075136
|
AABR07051726.1
|
|
chr3_+_11763706 | 5.14 |
ENSRNOT00000078366
|
Sh2d3c
|
SH2 domain containing 3C |
chrX_+_112311251 | 5.13 |
ENSRNOT00000086698
|
AABR07040855.1
|
|
chr4_-_164406146 | 5.12 |
ENSRNOT00000090110
|
Klra22
|
killer cell lectin-like receptor subfamily A, member 22 |
chr11_+_85430400 | 5.11 |
ENSRNOT00000083198
|
AABR07034729.1
|
|
chr13_-_91981432 | 5.10 |
ENSRNOT00000004637
|
AABR07021804.1
|
|
chr1_-_252808380 | 5.09 |
ENSRNOT00000025856
|
Ch25h
|
cholesterol 25-hydroxylase |
chr10_-_89130339 | 5.08 |
ENSRNOT00000027640
|
Ezh1
|
enhancer of zeste 1 polycomb repressive complex 2 subunit |
chr7_-_5818625 | 5.07 |
ENSRNOT00000051699
|
Olr886
|
olfactory receptor 886 |
chr12_+_24761210 | 5.04 |
ENSRNOT00000002003
|
Cldn4
|
claudin 4 |
chr9_+_10013854 | 5.02 |
ENSRNOT00000077653
ENSRNOT00000072033 |
Khsrp
|
KH-type splicing regulatory protein |
chr1_+_227240383 | 4.99 |
ENSRNOT00000074127
|
Ms4a6e
|
membrane spanning 4-domains A6E |
chr6_+_86785771 | 4.99 |
ENSRNOT00000066702
|
Prpf39
|
pre-mRNA processing factor 39 |
chr20_+_3155652 | 4.97 |
ENSRNOT00000042882
|
RT1-S2
|
RT1 class Ib, locus S2 |
chr11_+_31539016 | 4.96 |
ENSRNOT00000072856
|
Ifnar2
|
interferon alpha and beta receptor subunit 2 |
chr3_+_19174027 | 4.96 |
ENSRNOT00000074445
|
AABR07051678.1
|
|
chr8_+_69127708 | 4.95 |
ENSRNOT00000013490
|
Snapc5
|
small nuclear RNA activating complex, polypeptide 5 |
chr8_+_117117430 | 4.94 |
ENSRNOT00000073247
|
Gpx1
|
glutathione peroxidase 1 |
chr7_-_142180997 | 4.93 |
ENSRNOT00000087632
|
Tfcp2
|
transcription factor CP2 |
chr4_-_165192647 | 4.92 |
ENSRNOT00000086461
|
Klra5
|
killer cell lectin-like receptor, subfamily A, member 5 |
chr1_+_60117804 | 4.90 |
ENSRNOT00000080437
|
Vom1r8
|
vomeronasal 1 receptor 8 |
chr9_+_95295701 | 4.89 |
ENSRNOT00000025045
|
Ugt1a5
|
UDP glucuronosyltransferase family 1 member A5 |
chr10_-_34961608 | 4.88 |
ENSRNOT00000033056
|
LOC103689931
|
heterogeneous nuclear ribonucleoprotein A/B |
chr19_+_53044379 | 4.86 |
ENSRNOT00000072369
|
Foxc2
|
forkhead box C2 |
chr1_-_101819478 | 4.85 |
ENSRNOT00000056181
|
Grwd1
|
glutamate-rich WD repeat containing 1 |
chr15_-_82581916 | 4.81 |
ENSRNOT00000057891
|
RGD1560069
|
similar to ribosomal protein L27 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.9 | 26.6 | GO:0016487 | sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
8.9 | 35.5 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
6.7 | 20.0 | GO:0018924 | mandelate metabolic process(GO:0018924) |
5.3 | 15.8 | GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate(GO:0019265) |
4.9 | 14.8 | GO:0097187 | dentinogenesis(GO:0097187) regulation of sodium-dependent phosphate transport(GO:2000118) |
4.9 | 19.6 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
4.6 | 4.6 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
4.2 | 16.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
3.9 | 15.8 | GO:0097069 | cellular response to thyroxine stimulus(GO:0097069) |
3.6 | 18.2 | GO:0002003 | angiotensin maturation(GO:0002003) |
3.4 | 16.9 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
3.3 | 10.0 | GO:0036446 | myofibroblast differentiation(GO:0036446) response to methyl methanesulfonate(GO:0072702) cellular response to methyl methanesulfonate(GO:0072703) regulation of myofibroblast differentiation(GO:1904760) |
3.2 | 9.7 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
3.2 | 9.6 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
3.1 | 9.4 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
3.0 | 8.9 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
2.9 | 8.7 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
2.8 | 8.5 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
2.8 | 11.3 | GO:1902569 | regulation of activation of JAK2 kinase activity(GO:0010534) activation of JAK2 kinase activity(GO:0042977) negative regulation of activation of JAK2 kinase activity(GO:1902569) |
2.8 | 25.1 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
2.6 | 28.5 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
2.5 | 7.6 | GO:0019677 | NADP catabolic process(GO:0006742) NAD catabolic process(GO:0019677) |
2.4 | 9.4 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
2.1 | 6.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
1.9 | 5.7 | GO:0060974 | cell migration involved in heart formation(GO:0060974) |
1.9 | 5.7 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
1.9 | 13.3 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
1.9 | 5.7 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
1.8 | 20.1 | GO:0015747 | urate transport(GO:0015747) |
1.8 | 5.3 | GO:0090024 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) |
1.8 | 7.0 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
1.8 | 7.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.7 | 6.9 | GO:0031179 | peptide modification(GO:0031179) |
1.6 | 4.9 | GO:0009609 | response to symbiotic bacterium(GO:0009609) |
1.6 | 3.3 | GO:0009608 | response to symbiont(GO:0009608) |
1.6 | 8.0 | GO:0010037 | response to carbon dioxide(GO:0010037) |
1.6 | 9.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.5 | 4.5 | GO:1901227 | negative regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901227) |
1.5 | 6.0 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
1.4 | 13.0 | GO:0070543 | response to linoleic acid(GO:0070543) |
1.4 | 2.9 | GO:2000464 | positive regulation of astrocyte chemotaxis(GO:2000464) |
1.4 | 10.1 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
1.4 | 8.6 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.4 | 4.2 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
1.4 | 2.8 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
1.4 | 15.1 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
1.4 | 4.1 | GO:0071350 | interleukin-12-mediated signaling pathway(GO:0035722) interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-12(GO:0071349) cellular response to interleukin-15(GO:0071350) regulation of monocyte extravasation(GO:2000437) |
1.4 | 4.1 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
1.3 | 5.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
1.2 | 7.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
1.2 | 3.6 | GO:0045210 | negative regulation of dendritic cell cytokine production(GO:0002731) FasL biosynthetic process(GO:0045210) |
1.2 | 17.9 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
1.2 | 4.7 | GO:0098705 | copper ion import across plasma membrane(GO:0098705) copper ion import into cell(GO:1902861) |
1.2 | 8.1 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.2 | 3.5 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
1.2 | 2.3 | GO:0009644 | response to high light intensity(GO:0009644) |
1.1 | 12.6 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.1 | 9.2 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.1 | 5.7 | GO:0030070 | insulin processing(GO:0030070) |
1.1 | 3.4 | GO:1903936 | cellular response to sodium arsenite(GO:1903936) |
1.1 | 4.5 | GO:0048252 | lauric acid metabolic process(GO:0048252) |
1.1 | 5.6 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.1 | 3.3 | GO:1900673 | olefin metabolic process(GO:1900673) |
1.1 | 5.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.1 | 3.3 | GO:0071461 | cellular response to redox state(GO:0071461) |
1.1 | 10.6 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
1.0 | 2.1 | GO:0097214 | regulation of lysosomal membrane permeability(GO:0097213) positive regulation of lysosomal membrane permeability(GO:0097214) |
1.0 | 23.9 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
1.0 | 5.2 | GO:0009758 | carbohydrate utilization(GO:0009758) |
1.0 | 3.1 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
1.0 | 3.1 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
1.0 | 3.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.0 | 3.1 | GO:2000422 | regulation of eosinophil chemotaxis(GO:2000422) positive regulation of eosinophil chemotaxis(GO:2000424) |
1.0 | 6.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
1.0 | 8.0 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
1.0 | 9.9 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
1.0 | 4.0 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
1.0 | 3.9 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.0 | 2.9 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.0 | 9.6 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
1.0 | 41.1 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
1.0 | 43.0 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.9 | 10.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.9 | 3.8 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.9 | 1.8 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.9 | 2.7 | GO:0071245 | cellular response to carbon monoxide(GO:0071245) |
0.9 | 3.5 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.9 | 4.4 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.9 | 4.4 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.9 | 2.6 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
0.9 | 4.3 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) pericentric heterochromatin assembly(GO:0031508) |
0.9 | 2.6 | GO:0036395 | pancreatic amylase secretion(GO:0036395) regulation of pancreatic amylase secretion(GO:1902276) positive regulation of histamine secretion by mast cell(GO:1903595) |
0.9 | 1.7 | GO:0000958 | mitochondrial mRNA catabolic process(GO:0000958) positive regulation of mitochondrial RNA catabolic process(GO:0000962) |
0.8 | 0.8 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
0.8 | 3.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.8 | 8.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.8 | 4.8 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.8 | 3.2 | GO:0035772 | interleukin-13-mediated signaling pathway(GO:0035772) |
0.8 | 2.4 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.8 | 2.4 | GO:0034031 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) acetyl-CoA catabolic process(GO:0046356) |
0.8 | 9.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.8 | 5.3 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.7 | 20.2 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.7 | 2.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.7 | 2.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.7 | 2.2 | GO:0051933 | lactate biosynthetic process(GO:0019249) amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.7 | 1.5 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.7 | 2.2 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.7 | 2.2 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.7 | 5.0 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.7 | 2.9 | GO:0070269 | pyroptosis(GO:0070269) |
0.7 | 4.3 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.7 | 3.6 | GO:0001555 | oocyte growth(GO:0001555) |
0.7 | 4.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.7 | 2.1 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.7 | 2.8 | GO:1990375 | baculum development(GO:1990375) |
0.7 | 2.1 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.7 | 3.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.7 | 2.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.7 | 2.7 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.7 | 3.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.7 | 4.7 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.7 | 2.0 | GO:0000105 | histidine biosynthetic process(GO:0000105) |
0.7 | 9.3 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.7 | 2.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.7 | 5.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.6 | 3.9 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.6 | 2.6 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.6 | 12.2 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.6 | 4.4 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.6 | 3.1 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.6 | 2.5 | GO:2000814 | positive regulation of barbed-end actin filament capping(GO:2000814) |
0.6 | 1.8 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.6 | 1.8 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.6 | 3.5 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.6 | 2.9 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.6 | 9.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.6 | 2.9 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.6 | 2.3 | GO:0032701 | negative regulation of interleukin-18 production(GO:0032701) |
0.6 | 5.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.6 | 6.8 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.6 | 2.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.6 | 5.6 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.6 | 10.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.6 | 2.8 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.6 | 4.4 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.5 | 4.4 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.5 | 2.7 | GO:0098953 | gamma-aminobutyric acid receptor clustering(GO:0097112) receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
0.5 | 2.1 | GO:0006272 | leading strand elongation(GO:0006272) |
0.5 | 1.6 | GO:0052572 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.5 | 1.6 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
0.5 | 1.6 | GO:0006431 | methionyl-tRNA aminoacylation(GO:0006431) |
0.5 | 6.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.5 | 1.5 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.5 | 3.0 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.5 | 4.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.5 | 1.5 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.5 | 4.0 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.5 | 4.9 | GO:0009642 | response to light intensity(GO:0009642) |
0.5 | 1.0 | GO:0072347 | response to anesthetic(GO:0072347) |
0.5 | 6.3 | GO:0050718 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.5 | 1.9 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.5 | 1.4 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.5 | 1.4 | GO:0070295 | renal water absorption(GO:0070295) |
0.5 | 4.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.5 | 19.5 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.5 | 1.4 | GO:1904835 | vestibulocochlear nerve structural organization(GO:0021649) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) |
0.5 | 2.4 | GO:0060327 | cytoplasmic actin-based contraction involved in cell motility(GO:0060327) |
0.5 | 2.3 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.5 | 3.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.5 | 4.1 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.5 | 3.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.5 | 5.5 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.5 | 3.6 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.4 | 2.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.4 | 3.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.4 | 3.5 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.4 | 2.2 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.4 | 1.3 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.4 | 1.3 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.4 | 1.7 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.4 | 1.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.4 | 3.9 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.4 | 1.7 | GO:1904923 | regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) |
0.4 | 3.0 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.4 | 6.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.4 | 5.5 | GO:0046415 | urate metabolic process(GO:0046415) |
0.4 | 4.5 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.4 | 4.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.4 | 5.3 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.4 | 2.4 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.4 | 3.2 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.4 | 1.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.4 | 2.8 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.4 | 10.8 | GO:0042168 | heme metabolic process(GO:0042168) |
0.4 | 4.0 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.4 | 3.6 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.4 | 5.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.4 | 2.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.4 | 1.5 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.4 | 1.1 | GO:0048382 | lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) mesendoderm development(GO:0048382) regulation of cardiac ventricle development(GO:1904412) |
0.4 | 4.5 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.4 | 1.9 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.4 | 1.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.4 | 1.5 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.4 | 1.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.4 | 1.1 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
0.4 | 1.1 | GO:0009597 | detection of virus(GO:0009597) |
0.4 | 9.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.4 | 1.1 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.4 | 1.4 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.4 | 3.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.4 | 2.1 | GO:1903142 | negative regulation of excitatory postsynaptic potential(GO:0090394) positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.3 | 6.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.3 | 2.7 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.3 | 5.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.3 | 4.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.3 | 0.7 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.3 | 0.7 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.3 | 1.0 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.3 | 2.0 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.3 | 0.3 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.3 | 1.0 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.3 | 6.3 | GO:0032288 | myelin assembly(GO:0032288) |
0.3 | 0.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.3 | 2.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 1.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 3.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 1.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.3 | 1.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.3 | 12.1 | GO:1901998 | toxin transport(GO:1901998) |
0.3 | 8.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.3 | 0.9 | GO:1905168 | positive regulation of double-strand break repair via homologous recombination(GO:1905168) |
0.3 | 0.9 | GO:0060383 | positive regulation of DNA strand elongation(GO:0060383) |
0.3 | 2.2 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.3 | 0.6 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.3 | 3.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 0.9 | GO:2000017 | endocardial cushion cell differentiation(GO:0061443) positive regulation of determination of dorsal identity(GO:2000017) |
0.3 | 9.5 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.3 | 2.9 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.3 | 2.9 | GO:0097264 | self proteolysis(GO:0097264) |
0.3 | 5.2 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.3 | 1.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 2.0 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.3 | 1.7 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.3 | 3.4 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.3 | 1.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.3 | 1.4 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.3 | 1.1 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.3 | 1.4 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.3 | 1.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 2.7 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.3 | 1.8 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.3 | 1.1 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.3 | 3.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.3 | 1.6 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) cellular response to leucine(GO:0071233) |
0.3 | 2.9 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.3 | 2.6 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.3 | 1.0 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.3 | 4.4 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.3 | 1.0 | GO:1903413 | cellular response to bile acid(GO:1903413) |
0.3 | 6.9 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.3 | 2.0 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 1.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 1.2 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.2 | 2.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.2 | 3.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 5.7 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 2.3 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 2.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.9 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 0.7 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.2 | 0.9 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.2 | 1.6 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 2.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 1.8 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 4.0 | GO:0042119 | neutrophil activation(GO:0042119) |
0.2 | 4.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 5.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 2.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 2.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 3.2 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.2 | 0.6 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.2 | 0.9 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 1.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 1.7 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.2 | 2.5 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.2 | 2.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 6.5 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.2 | 1.2 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.2 | 0.8 | GO:0060594 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) mammary gland specification(GO:0060594) |
0.2 | 5.7 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 6.3 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.2 | 3.2 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.2 | 1.0 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.2 | 4.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 5.8 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.2 | 2.9 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.2 | 2.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 0.6 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.2 | 0.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.2 | 3.8 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 1.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 0.5 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.2 | 1.6 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 2.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 2.6 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.2 | 0.3 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.2 | 0.9 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.2 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 2.9 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.2 | 1.0 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.2 | 4.4 | GO:0009303 | rRNA transcription(GO:0009303) |
0.2 | 3.9 | GO:1904894 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.2 | 0.5 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.2 | 4.0 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.2 | 7.2 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) |
0.2 | 1.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 2.8 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 2.5 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.2 | 1.0 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.2 | 3.1 | GO:0007567 | parturition(GO:0007567) |
0.2 | 10.7 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.2 | 3.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.2 | 1.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.2 | 0.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 9.7 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.2 | 2.7 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.2 | 0.5 | GO:0021997 | neural plate axis specification(GO:0021997) |
0.2 | 5.1 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.2 | 0.5 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.2 | 2.9 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.2 | 1.5 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.2 | 1.4 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) induction of positive chemotaxis(GO:0050930) |
0.2 | 4.4 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 5.5 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.7 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.1 | 0.7 | GO:1904400 | response to Thyroid stimulating hormone(GO:1904400) cellular response to Thyroid stimulating hormone(GO:1904401) |
0.1 | 2.9 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.1 | 1.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 199.2 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.1 | 0.7 | GO:0003360 | brainstem development(GO:0003360) |
0.1 | 7.6 | GO:0033574 | response to testosterone(GO:0033574) |
0.1 | 3.6 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.4 | GO:0002188 | translation reinitiation(GO:0002188) |
0.1 | 0.8 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 1.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 4.0 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 1.1 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 1.4 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 5.7 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.1 | 3.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 1.3 | GO:0032674 | regulation of interleukin-5 production(GO:0032674) |
0.1 | 0.6 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 9.9 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.1 | 1.6 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 1.0 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 1.6 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 1.1 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.1 | 2.0 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.6 | GO:1902022 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
0.1 | 0.4 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.1 | 0.3 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.1 | 1.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.7 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.1 | 1.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 1.4 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 4.7 | GO:0042220 | response to cocaine(GO:0042220) |
0.1 | 0.5 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 4.0 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.1 | 0.4 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 1.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.6 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 3.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 4.4 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.1 | 0.5 | GO:0061709 | reticulophagy(GO:0061709) |
0.1 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 4.2 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.1 | 1.9 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.9 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.6 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.2 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.1 | 0.6 | GO:0046512 | sphingosine biosynthetic process(GO:0046512) |
0.1 | 1.9 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.2 | GO:0043201 | response to leucine(GO:0043201) |
0.1 | 0.6 | GO:0045059 | positive regulation of T cell differentiation in thymus(GO:0033089) positive thymic T cell selection(GO:0045059) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 1.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 1.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.6 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 1.7 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.1 | 0.5 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 2.5 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 1.0 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 1.3 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.1 | 0.4 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 | 0.2 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
0.1 | 1.2 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.1 | 0.9 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 5.4 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.7 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 2.2 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.1 | 0.3 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 2.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 1.0 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.1 | 5.2 | GO:0010906 | regulation of glucose metabolic process(GO:0010906) |
0.1 | 1.5 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.1 | 0.8 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 1.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.9 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 6.7 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.1 | 1.2 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 0.6 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 2.3 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 1.4 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.1 | 0.2 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.1 | 1.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 1.9 | GO:0097202 | activation of cysteine-type endopeptidase activity(GO:0097202) |
0.1 | 1.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 6.6 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.1 | 1.2 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.1 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.1 | 0.4 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.8 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.1 | 0.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 1.1 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.1 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.0 | 0.8 | GO:0010458 | exit from mitosis(GO:0010458) |
0.0 | 1.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.8 | GO:0097502 | mannosylation(GO:0097502) |
0.0 | 1.2 | GO:0001885 | endothelial cell development(GO:0001885) |
0.0 | 2.1 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 10.4 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.1 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.0 | 2.7 | GO:0060996 | dendritic spine development(GO:0060996) |
0.0 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 1.3 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
0.0 | 1.5 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.6 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 3.9 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.0 | 0.6 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.5 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.8 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 1.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.2 | GO:0031497 | chromatin assembly(GO:0031497) |
0.0 | 0.1 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.0 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 13.6 | GO:0006955 | immune response(GO:0006955) |
0.0 | 0.5 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 1.2 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.5 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.4 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.6 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 1.8 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 0.4 | GO:0031572 | mitotic G2 DNA damage checkpoint(GO:0007095) G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.5 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.3 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.0 | 0.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.8 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 7.4 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 2.1 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.0 | 0.3 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.0 | 0.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.0 | 0.0 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.0 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.0 | 0.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 1.0 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.3 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.5 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.3 | GO:0033045 | regulation of sister chromatid segregation(GO:0033045) |
0.0 | 0.4 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.7 | GO:0032398 | MHC class Ib protein complex(GO:0032398) |
3.2 | 3.2 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
2.8 | 8.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
2.1 | 8.5 | GO:0044299 | C-fiber(GO:0044299) |
2.0 | 9.9 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
1.8 | 7.3 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
1.6 | 11.3 | GO:0005579 | membrane attack complex(GO:0005579) |
1.6 | 6.3 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
1.4 | 5.7 | GO:0061702 | inflammasome complex(GO:0061702) |
1.4 | 4.1 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
1.2 | 18.4 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
1.1 | 3.4 | GO:1990826 | nucleoplasmic periphery of the nuclear pore complex(GO:1990826) |
1.1 | 3.4 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
1.1 | 56.1 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
1.1 | 3.2 | GO:0070826 | paraferritin complex(GO:0070826) |
1.0 | 7.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.0 | 8.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.0 | 4.9 | GO:0097413 | Lewy body(GO:0097413) |
0.9 | 2.8 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.9 | 3.6 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.9 | 3.6 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.9 | 4.4 | GO:0071953 | elastic fiber(GO:0071953) |
0.9 | 2.6 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.9 | 6.8 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.8 | 6.2 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.8 | 0.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.8 | 2.3 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.7 | 2.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.7 | 3.7 | GO:0000243 | commitment complex(GO:0000243) |
0.7 | 14.5 | GO:0019013 | viral nucleocapsid(GO:0019013) |
0.7 | 3.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.7 | 10.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.7 | 2.1 | GO:1990836 | lysosomal matrix(GO:1990836) |
0.7 | 3.4 | GO:0070552 | BRISC complex(GO:0070552) |
0.7 | 6.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.7 | 3.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.7 | 1.3 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.7 | 3.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.6 | 1.9 | GO:0045025 | mitochondrial degradosome(GO:0045025) |
0.6 | 1.9 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.6 | 53.7 | GO:0031526 | brush border membrane(GO:0031526) |
0.6 | 1.9 | GO:0045203 | intrinsic component of cell outer membrane(GO:0031230) integral component of cell outer membrane(GO:0045203) |
0.6 | 1.8 | GO:1990032 | parallel fiber(GO:1990032) |
0.6 | 17.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.6 | 2.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.6 | 3.5 | GO:0070820 | tertiary granule(GO:0070820) |
0.6 | 7.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.6 | 9.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.5 | 4.3 | GO:0001740 | Barr body(GO:0001740) |
0.5 | 2.1 | GO:0061474 | phagolysosome(GO:0032010) phagolysosome membrane(GO:0061474) |
0.5 | 10.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.5 | 8.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.5 | 1.5 | GO:0044317 | rod spherule(GO:0044317) |
0.5 | 4.7 | GO:0032437 | cuticular plate(GO:0032437) |
0.5 | 9.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.5 | 2.7 | GO:0098871 | postsynaptic actin cytoskeleton(GO:0098871) postsynaptic cytoskeleton(GO:0099571) |
0.5 | 0.9 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.4 | 3.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.4 | 5.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.4 | 1.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.4 | 1.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.4 | 1.6 | GO:0097196 | Shu complex(GO:0097196) |
0.4 | 4.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 4.2 | GO:0044754 | autolysosome(GO:0044754) |
0.4 | 1.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.4 | 2.3 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.4 | 2.2 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.4 | 1.8 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.4 | 2.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 1.4 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.3 | 1.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 1.4 | GO:0042585 | germinal vesicle(GO:0042585) dendritic branch(GO:0044307) |
0.3 | 26.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.3 | 8.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 50.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.3 | 1.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.3 | 2.4 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 4.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.3 | 1.8 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.3 | 8.2 | GO:0070469 | respiratory chain(GO:0070469) |
0.3 | 7.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 3.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.3 | 2.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.3 | 2.8 | GO:0001939 | female pronucleus(GO:0001939) |
0.3 | 1.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 1.5 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.3 | 5.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 2.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 9.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 2.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 23.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 0.7 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 1.1 | GO:0034455 | t-UTP complex(GO:0034455) |
0.2 | 1.8 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 3.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 1.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 3.0 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 1.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 5.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 3.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 6.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 2.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 59.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 1.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 2.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 1.9 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 0.9 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 0.6 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.2 | 0.9 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.4 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 2.3 | GO:0000801 | central element(GO:0000801) |
0.2 | 1.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 13.1 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 1.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 3.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 2.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 3.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 14.2 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.2 | 3.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.6 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 3.9 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 6.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 1.0 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 2.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 3.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 1.5 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.1 | 1.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.8 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 1.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.9 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 3.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 29.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 1.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.7 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 7.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 11.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.9 | GO:0070187 | telosome(GO:0070187) |
0.1 | 5.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 28.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 5.6 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 2.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.9 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.1 | 0.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 10.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 13.8 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 69.8 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 1.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 1.8 | GO:0031082 | BLOC complex(GO:0031082) |
0.1 | 0.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.8 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 5.1 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 3.3 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 0.5 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 1.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 6.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 4.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 2.5 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 1.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 160.2 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 1.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 2.8 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.6 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 4.1 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 12.2 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.8 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.3 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 2.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 1.6 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 16.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 1.7 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.0 | 0.3 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 6.9 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 2.0 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 1.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 1.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 1.8 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.0 | 127.0 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.0 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.9 | 26.6 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) |
7.6 | 22.9 | GO:0004556 | alpha-amylase activity(GO:0004556) |
6.7 | 20.0 | GO:0052853 | very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
3.6 | 17.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
3.6 | 28.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
3.2 | 9.7 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
3.2 | 15.8 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
3.1 | 12.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
3.1 | 9.3 | GO:0017042 | glycosylceramidase activity(GO:0017042) |
3.0 | 14.8 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
2.7 | 8.1 | GO:0004925 | prolactin receptor activity(GO:0004925) |
2.6 | 7.8 | GO:0031714 | C5a anaphylatoxin chemotactic receptor binding(GO:0031714) |
2.5 | 10.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
2.5 | 9.9 | GO:0051870 | methotrexate binding(GO:0051870) |
2.3 | 9.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
2.3 | 62.1 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
2.1 | 8.3 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
2.1 | 12.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
2.0 | 20.1 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.9 | 7.6 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.9 | 5.7 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
1.9 | 5.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.8 | 7.3 | GO:0019002 | GMP binding(GO:0019002) |
1.7 | 5.2 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
1.7 | 5.0 | GO:0019961 | interferon binding(GO:0019961) |
1.6 | 9.7 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
1.6 | 6.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.5 | 7.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.5 | 13.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
1.5 | 4.4 | GO:0008405 | arachidonic acid 11,12-epoxygenase activity(GO:0008405) |
1.4 | 4.1 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
1.4 | 8.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
1.3 | 5.3 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
1.3 | 7.9 | GO:0032027 | myosin light chain binding(GO:0032027) |
1.3 | 7.6 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.2 | 6.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
1.1 | 3.4 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.1 | 6.8 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
1.1 | 5.5 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
1.1 | 4.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.1 | 4.4 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
1.1 | 3.2 | GO:0001605 | adrenomedullin receptor activity(GO:0001605) |
1.1 | 3.2 | GO:0047708 | biotinidase activity(GO:0047708) |
1.0 | 2.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.0 | 18.9 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
1.0 | 2.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.0 | 3.9 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) PTB domain binding(GO:0051425) |
0.9 | 2.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.9 | 11.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.9 | 11.8 | GO:1990405 | protein antigen binding(GO:1990405) |
0.9 | 8.0 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.9 | 8.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.9 | 3.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.9 | 15.8 | GO:0016595 | glutamate binding(GO:0016595) |
0.9 | 3.5 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.8 | 5.9 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.8 | 3.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.8 | 7.3 | GO:0015266 | protein channel activity(GO:0015266) P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.8 | 25.0 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.8 | 2.4 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.8 | 6.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.8 | 3.1 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
0.8 | 3.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.8 | 2.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.7 | 15.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.7 | 2.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.7 | 74.0 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.7 | 5.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.7 | 8.7 | GO:0005542 | folic acid binding(GO:0005542) |
0.7 | 14.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.7 | 4.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.7 | 3.4 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.7 | 2.7 | GO:0008940 | nitrate reductase activity(GO:0008940) |
0.7 | 2.7 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.7 | 3.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.7 | 4.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.7 | 18.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.6 | 1.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.6 | 8.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.6 | 5.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.6 | 3.7 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.6 | 0.6 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.6 | 9.2 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.6 | 1.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.6 | 13.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.6 | 2.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.6 | 7.1 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.6 | 4.7 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.6 | 5.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.6 | 2.9 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.6 | 2.3 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.6 | 10.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.6 | 3.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.6 | 40.3 | GO:0003823 | antigen binding(GO:0003823) |
0.5 | 1.6 | GO:0000991 | transcription factor activity, core RNA polymerase II binding(GO:0000991) |
0.5 | 7.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.5 | 2.7 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.5 | 2.7 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.5 | 14.9 | GO:0008527 | taste receptor activity(GO:0008527) |
0.5 | 6.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.5 | 1.6 | GO:0004825 | methionine-tRNA ligase activity(GO:0004825) |
0.5 | 7.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.5 | 10.8 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.5 | 2.0 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.5 | 8.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.5 | 14.9 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.5 | 3.5 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.5 | 2.9 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.5 | 3.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.5 | 1.4 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.5 | 3.8 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.5 | 6.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.5 | 1.9 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.5 | 2.9 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.5 | 9.8 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.5 | 5.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.5 | 1.8 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.5 | 1.8 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.5 | 2.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.4 | 1.8 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.4 | 4.4 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.4 | 2.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.4 | 2.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.4 | 9.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.4 | 0.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.4 | 5.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 4.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.4 | 5.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.4 | 10.7 | GO:0042287 | MHC protein binding(GO:0042287) |
0.4 | 9.0 | GO:0051861 | glycolipid binding(GO:0051861) |
0.4 | 1.6 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.4 | 3.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.4 | 3.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 5.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.4 | 1.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 4.6 | GO:0070402 | NADPH binding(GO:0070402) |
0.4 | 2.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.4 | 6.6 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.4 | 0.7 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.4 | 1.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.4 | 2.8 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.3 | 1.4 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 4.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 1.0 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.3 | 1.7 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 3.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) superoxide-generating NADPH oxidase activity(GO:0016175) |
0.3 | 1.4 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.3 | 3.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 4.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 3.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.3 | 3.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.3 | 0.9 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.3 | 5.5 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.3 | 2.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.3 | 1.5 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.3 | 2.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 5.3 | GO:0008483 | transaminase activity(GO:0008483) |
0.3 | 2.6 | GO:0001846 | opsonin binding(GO:0001846) |
0.3 | 1.5 | GO:0001093 | TFIIB-class transcription factor binding(GO:0001093) |
0.3 | 1.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 16.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.3 | 2.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 1.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.3 | 1.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 1.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 3.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 0.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 1.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.3 | 21.0 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.3 | 1.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 1.5 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 4.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 1.0 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.2 | 1.2 | GO:0004586 | ornithine decarboxylase activity(GO:0004586) |
0.2 | 1.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 2.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 3.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.2 | 1.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 4.2 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 4.6 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 1.4 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 0.9 | GO:0017002 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.2 | 4.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 4.5 | GO:0004601 | peroxidase activity(GO:0004601) |
0.2 | 1.8 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 1.7 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 0.6 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 4.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 2.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 5.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.0 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.2 | 0.8 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 6.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 1.6 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 5.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 3.9 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 1.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 4.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 3.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 3.1 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 1.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 2.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 1.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 5.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 4.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 2.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 0.6 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.2 | 4.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 17.9 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.2 | 1.4 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 5.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 1.6 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 1.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 4.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.2 | 9.5 | GO:0051287 | NAD binding(GO:0051287) |
0.2 | 7.3 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.2 | 68.0 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 47.4 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.2 | 4.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 2.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 2.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 1.4 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.2 | 1.6 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 4.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 0.5 | GO:0005119 | smoothened binding(GO:0005119) |
0.2 | 6.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 0.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 1.4 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) NAD-dependent protein deacetylase activity(GO:0034979) |
0.2 | 0.5 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.2 | 0.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 3.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.1 | 1.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 1.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 2.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 1.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.7 | GO:0055104 | ligase inhibitor activity(GO:0055104) large ribosomal subunit rRNA binding(GO:0070180) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 13.4 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.1 | 4.0 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 54.5 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 5.4 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 0.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 8.3 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 1.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.6 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 1.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 2.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 1.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 5.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 6.0 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 1.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 2.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 27.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 2.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 1.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 1.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 19.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 1.3 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.6 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 1.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 80.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 2.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 2.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 10.7 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 5.4 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 0.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.9 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 1.0 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 1.5 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 2.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 2.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 1.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.3 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 4.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.2 | GO:0015292 | uniporter activity(GO:0015292) |
0.1 | 0.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.2 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.1 | 1.3 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 1.4 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 2.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 10.2 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 2.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 1.1 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.3 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 1.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 1.5 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 2.6 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.0 | 0.5 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 1.7 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) endothelin receptor activity(GO:0004962) |
0.0 | 1.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 7.3 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.8 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 1.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 9.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 1.9 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 1.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 25.2 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 1.8 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 7.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.0 | 0.5 | GO:0017171 | serine-type peptidase activity(GO:0008236) serine hydrolase activity(GO:0017171) |
0.0 | 0.5 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 1.5 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.9 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.6 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.1 | GO:0035375 | zymogen binding(GO:0035375) |
0.0 | 0.2 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.3 | GO:0016896 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.0 | 3.8 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.0 | 1.2 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.0 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 17.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.8 | 2.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.6 | 7.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.6 | 32.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.6 | 9.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.5 | 3.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.5 | 1.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.4 | 6.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 24.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 7.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 3.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 22.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 21.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.3 | 12.9 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 2.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 13.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 4.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 1.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 7.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 8.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 5.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 10.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 4.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 1.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 6.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 5.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 3.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 3.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 4.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 4.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 4.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 4.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 2.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 3.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 24.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 3.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 5.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 9.2 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 6.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 1.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 3.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 4.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 2.3 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 10.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 4.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 2.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 5.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 2.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 2.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 8.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 1.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 3.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 3.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 2.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 1.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 2.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 2.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.0 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 1.5 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 12.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.9 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.0 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 1.1 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 1.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 1.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.5 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.4 | PID P73PATHWAY | p73 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 29.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.7 | 15.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.2 | 15.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
1.0 | 15.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.9 | 13.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.9 | 44.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.8 | 24.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.8 | 4.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.8 | 15.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.8 | 4.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.8 | 9.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.8 | 9.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.8 | 13.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.6 | 7.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.6 | 7.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.6 | 6.9 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.6 | 21.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 5.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 14.5 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.5 | 3.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.5 | 1.5 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.5 | 17.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.4 | 8.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.4 | 6.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.4 | 14.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.4 | 7.5 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.4 | 8.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.4 | 8.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.4 | 7.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.4 | 9.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.4 | 6.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 19.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.3 | 8.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 3.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 12.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 5.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 5.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 3.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.3 | 3.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 3.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 5.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.3 | 5.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.3 | 5.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 5.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 4.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.3 | 1.8 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.3 | 5.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.3 | 3.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.3 | 2.0 | REACTOME DEFENSINS | Genes involved in Defensins |
0.3 | 5.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.2 | 4.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 13.0 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 2.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 12.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 5.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 5.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 3.4 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.2 | 3.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 2.8 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 1.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 10.7 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 6.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 7.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 3.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 2.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 6.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 3.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 2.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 1.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 9.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 2.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 10.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 6.7 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.2 | 6.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 3.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 1.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 2.2 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.1 | 1.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 2.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 2.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 3.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 5.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 2.7 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 3.8 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 1.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 2.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 2.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 2.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 3.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 1.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 5.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.7 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 1.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 2.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 9.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 1.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 3.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 2.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 5.7 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 1.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.7 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 3.6 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 0.8 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 2.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.5 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.0 | 0.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.3 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.0 | 0.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 0.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |